share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  04/03 05:07
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares on 04/02/2024, as per the latest filing. These shares, with an aggregate market value of $100,942.19, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This upcoming sale follows a series of transactions over the past three months, where a total of 111,717 shares were sold by Borgeson, generating gross proceeds of $1,297,128.07.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares on 04/02/2024, as per the latest filing. These shares, with an aggregate market value of $100,942.19, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This upcoming sale follows a series of transactions over the past three months, where a total of 111,717 shares were sold by Borgeson, generating gross proceeds of $1,297,128.07.
根據最新文件，Recursion Pharmicals, Inc.董事布萊克·博格森定於2024年2月4日出售11,447股A類股票。這些股票的總市值爲100,942.19美元，最初是作爲發行人薪酬的一部分於2016年1月9日作爲創始人股票收購的。此次即將進行的出售是在過去三個月進行的一系列交易之後進行的，博格森共出售了111,717股股票，總收益爲1,297,128.07美元。
根據最新文件，Recursion Pharmicals, Inc.董事布萊克·博格森定於2024年2月4日出售11,447股A類股票。這些股票的總市值爲100,942.19美元，最初是作爲發行人薪酬的一部分於2016年1月9日作爲創始人股票收購的。此次即將進行的出售是在過去三個月進行的一系列交易之後進行的，博格森共出售了111,717股股票，總收益爲1,297,128.07美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。